Seres Therapeutics Reports Second Quarter Financial Results and Provides Progress Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. HONA

Go back to Seres Therapeutics Reports Second Quarter Financial Results and Provides Progress Update

Seres Therapeutics (MCRB) Tops Q2 EPS by 24c, Revenues Beat

August 6, 2019 8:00 AM EDT

Seres Therapeutics (NASDAQ: MCRB) reported Q2 EPS of ($0.24), $0.24 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $12.53 million versus the consensus estimate of $8.13 million.

Four significant microbiome program milestones expected during 2020, including readouts from two late-stage development... More